Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)

Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -64.11%
Sep 30, 2025 -64.05%
Jun 30, 2025 -64.00%
Mar 31, 2025 -63.96%
Dec 31, 2024 -63.17%
Sep 30, 2024 -59.20%
Jun 30, 2024 -43.59%
Mar 31, 2024 7.28%
Dec 31, 2023 12.59%
Sep 30, 2023 16.33%
Jun 30, 2023 60.13%
Mar 31, 2023 56.37%
Dec 31, 2022 99.01%
Sep 30, 2022 91.29%
Jun 30, 2022 85.33%
Mar 31, 2022 79.37%
Dec 31, 2021 78.79%
Sep 30, 2021 72.74%
Jun 30, 2021 65.73%
Mar 31, 2021 61.02%